Nikhil Lalwani

PRESIDENT & CEO · ANI Pharmaceuticals

Nikhil Lalwani (PRESIDENT & CEO) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in ANI Pharmaceuticals, Inc. (ANIP). The largest single filing was $4.3M of ANIP (55,000 sh × $77.57, as filed), executed May 11. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$5.4M

shares × price, as filed

Last traded

Oct 15

Filed Oct 16

Median ADV $26.1M across their filed names

Open performance→

Volume by month

Buys $0 Sells $10.3M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

ANIP

ANI Pharmaceuticals, Inc. ANIP · 0 buys · 6 sells 6 filings

Recent filings

ANIPSALE ANI Pharmaceuticals, Inc. View filing → $388K
5,400 sh × $71.89
Exec Oct 15
Filed Oct 16 · 6:50 PM ET ANIPSALE ANI Pharmaceuticals, Inc. View filing → $383K
5,400 sh × $71.00
Exec Sep 15
Filed Sep 16 · 4:20 PM ET ANIPSALE ANI Pharmaceuticals, Inc. View filing → $401K
5,400 sh × $74.30
Exec Aug 25
Filed Aug 26 · 6:15 PM ET ANIPSALE ANI Pharmaceuticals, Inc. View filing → $4.3M
55,000 sh × $77.57
Exec May 11
Filed May 13 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. View filing → $4.9M
56,960 sh × $85.93
Exec Aug 12 2025
Filed Aug 14 2025 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. View filing → $1.9M
33,481 sh across 2 lots
Exec Nov 26 2024
Filed Nov 27 2024 · 5:30 PM ET